Clinical Trials Browser

Phase 1/2 × Imiquimod × Tumor-Agnostic × Clear all

NCT02224599 2020-04-24

Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies

Phase 1/2 Terminated

3 enrolled 6 charts

Neoplasms